Evaluation of a topical iron chelator in animals and in human beings: Short-term photoprotection by 2-furildioxime-Reference-Cited by-同舟云学术

Evaluation of a topical iron chelator in animals and in human beings: Short-term photoprotection by 2-furildioxime

Published:1994-10 Issue:4 Volume:31 Page:572-578
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Bissett Donald L.,Oelrich D. Mark,Hannon Daniel P.

Publisher

Elsevier BV

Subject

Dermatology

Reference22 articles.

1. Potential involvement of free radical reactions in ultraviolet light-mediated cutaneous damage;Black;Photochem Photobiol,1987

2. Photoprotective effect of superoxide-scavenging antioxidants against ultraviolet radiation-induced chronic skin damage in the hairless mouse;Bissett;Photodermatol Photoimmunol Photomed,1990

3. Chemoprevention of cutaneous carcinogenesis;Black;Cancer Bull,1983

4. Carotenoid dose level and protection against UV-B induced skin tumors;Mathews-Roth;Photochem Photobiol,1985

5. Activation of oxygen by metal complexes and its relevance to autoxidative processes in living systems;Buettner;Bioelectrochem Bioenerg,1987

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical Iron Chelator Therapy: Current Status and Future Prospects;Cureus;2023-10-26

2. Hyperpigmentation after sclerotherapy: modern possibilities for prevention and treatment;Ambulatornaya khirurgiya = Ambulatory Surgery (Russia);2023-05-19

3. Scalp application of the antioxidant piroctone olamine reduces hair shedding in an 8‐week randomized, double‐blind, placebo‐controlled clinical study;International Journal of Cosmetic Science;2021-10-12

4. Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24‐week randomized, double‐blind, placebo‐controlled clinical trial;International Journal of Cosmetic Science;2021-10-12

5. Complications and Adverse Sequelae of Sclerotherapy;Sclerotherapy;2017